Viewing Study NCT00045903



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00045903
Status: COMPLETED
Last Update Posted: 2014-04-23
First Post: 2002-09-13

Brief Title: Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
Sponsor: New York State Psychiatric Institute
Organization: New York State Psychiatric Institute

Study Overview

Official Title: CBT Augmentation for SRI Pharmacotherapy in OCD
Status: COMPLETED
Status Verified Date: 2012-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Aug1
Brief Summary: This study will evaluate the effectiveness of two cognitive behavioral therapies CBTs in treating obsessive compulsive disorder OCD in patients who are taking medication but still have residual symptoms
Detailed Description: Participants remain on their current OCD medication and are randomly assigned to receive one of two CBTs exposure and ritual prevention or stress management therapy Exposure and ritual prevention involves imaginal and in-vivo exposure and requires that participants refrain from ritualizing Stress management involves relaxation assertiveness training and structured problem-solving Therapy occurs twice per week for 2 months Participants are assessed verbally by an independent evaluator and are asked to complete self-rating forms Patients who respond are followed for up to 1 additional year Participants continue to take the same medication and the same monthly therapy for the first 6 months of follow-up During the second 6 months of follow-up participants discontinue therapy but continue taking the same medication

For information on a related study please follow this link

httpclinicaltrialsgovshowNCT00389493

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DSIR AT-CT US NIH GrantContract None httpsreporternihgovquickSearchR01MH045436-01
R01MH045436-01 NIH None None